encorafenibvemurafenibbinimetinibcobimetinibdabrafenibNIVO+RELAatezolizumabnivolumabtrametinibNIVO+IPI
…TEZO, atezolizumab; BINI, binimetinib; COBI, cobimetinib; ENCO, encorafenib; ESS, effective sample size; DAB, dabrafenib; NIVO, nivolumab; …
5articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: cobimetinib ×
cobimetinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning cobimetinib
5 articles · page 1 of 1pembrolizumabbortezomibcrizotinibpembrolizumab35sunitinibdasatinib
…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
dabrafenibatezolizumabcobimetinibbinimetinibtrametinibnivolumabvemurafenibencorafenibrelatlimabENCO+BINI+3 more
…(NIVO+RELA) to BRAF/MEK inhibitors, we compared its efficacy to dabrafenib+trametinib (DAB+TRAM), encorafenib+binimetinib (ENCO+BINI), vem…
AdagrasibasibpembrolizumabsotorasibBI-2493G12CidocetaxeldaraxonrasibAZD4785RMC-7977
…d OS of 13.4 months,38 39 leading to full FDA approval in 2024. Adagrasib has also shown modest activity in PDAC (ORR 33%, PFS 5.4 months…
tripolidePomalidomideImatinibcobimetinibdoxorubicinPHA-793887ST6GAL1
…rget effects and mechanistic insights.Results Perturbation with tripolide, doxorubicin, and cobimetinib resulted in dose dependent cell t…